http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114805631-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fea641961ea08c9adc7f9f8578e5acae
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-735
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-08
filingDate 2022-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b359f8b89809305228f872fa2626af21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e53ab90ee10fe88f72dfccb2c9db4fe1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2449b98c05f442da0dfe91ebf432df18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8922c1462ace1d82694a8604325298a
publicationDate 2022-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114805631-A
titleOfInvention Highly active hyaluronic acid-polypeptide conjugate and its preparation method and application
abstract The present invention discloses a highly active hyaluronic acid-polypeptide conjugate and its preparation method and application. Wherein, the preparation method of the highly active hyaluronic acid-polypeptide conjugate is: preparing aldehyde-modified hyaluronic acid; dissolving the aldehyde-modified hyaluronic acid in a buffer solution, adding auxin and sodium cyanoborohydride, and reacting ; Add ethyl carbazate to carry out the reaction; finally obtain a hyaluronic acid-polypeptide conjugate; the technical scheme of the present invention can perfectly connect auxin to hyaluronic acid, and the binding rate is about 70%; The secondary structure of the auxin in the hyaluronic acid-polypeptide conjugate did not change; and in the skin tissue test, the hyaluronic acid-polypeptide conjugate could effectively deliver to the dermis.
priorityDate 2022-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104302670-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113508143-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID162005732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454354098
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447855610
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421452099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450059958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20587905
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450770914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23662384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447816241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421069250
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23667635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10396794
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477116
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453740385

Total number of triples: 40.